CL2022000757A1 - Tienopirimidonas como inhibidores de trpa1 - Google Patents
Tienopirimidonas como inhibidores de trpa1Info
- Publication number
- CL2022000757A1 CL2022000757A1 CL2022000757A CL2022000757A CL2022000757A1 CL 2022000757 A1 CL2022000757 A1 CL 2022000757A1 CL 2022000757 A CL2022000757 A CL 2022000757A CL 2022000757 A CL2022000757 A CL 2022000757A CL 2022000757 A1 CL2022000757 A1 CL 2022000757A1
- Authority
- CL
- Chile
- Prior art keywords
- thienopyrimidones
- trpa1 inhibitors
- inhibitors
- diseases
- trpa1
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
La presente invención se refiere a tienopirimidinonas y a su uso como inhibidores de la actividad de TRPA1, a composiciones farmacéuticas que las contienen, y a métodos para usarlas como agentes para el tratamiento y/o la prevención de enfermedades fibróticas, enfermedades inflamatorias y autoinmunitarias y enfermedades relacionadas con el SNC.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP19203173 | 2019-10-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2022000757A1 true CL2022000757A1 (es) | 2023-01-20 |
Family
ID=68289874
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2022000757A CL2022000757A1 (es) | 2019-10-15 | 2022-03-25 | Tienopirimidonas como inhibidores de trpa1 |
Country Status (14)
Country | Link |
---|---|
US (2) | US20210107919A1 (es) |
EP (1) | EP4045144A1 (es) |
JP (1) | JP7354438B2 (es) |
KR (1) | KR20220084127A (es) |
CN (1) | CN114945408B (es) |
AR (1) | AR120221A1 (es) |
AU (1) | AU2020366678A1 (es) |
BR (1) | BR112022003729A2 (es) |
CA (1) | CA3153115A1 (es) |
CL (1) | CL2022000757A1 (es) |
IL (1) | IL292095A (es) |
MX (1) | MX2022004564A (es) |
TW (1) | TW202128705A (es) |
WO (1) | WO2021074197A1 (es) |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7754709B2 (en) * | 2003-06-10 | 2010-07-13 | Solvay Pharmaceuticals Bv | Tetracyclic thiophenepyrimidinone compounds as inhibitors of 17β hydroxysteroid dehydrogenase compounds |
CA2820448A1 (en) * | 2010-12-20 | 2012-06-28 | Glenmark Pharmaceuticals, S.A. | 2-amino-4-arylthiazole compounds as trpa1 antagonists |
WO2012172475A1 (en) * | 2011-06-13 | 2012-12-20 | Glenmark Pharmaceuticals S.A. | Treatment of respiratory disorders using trpa1 antagonists |
JP6573968B2 (ja) * | 2014-08-11 | 2019-09-11 | ハイドラ バイオサイエンシズ インコーポレイテッドHydra Biosciences,Inc. | TRPC5調節因子としての、精神神経障害の処置のためのチエノおよびフロ[2,3−d]ピリミジン−2,4[1H,3H]−ジオン誘導体 |
US12006328B2 (en) * | 2014-11-18 | 2024-06-11 | Emory University | Thieno[2,3-d]pyrimidin-4-one derivatives as NMDAR modulators and uses related thereto |
WO2016133888A1 (en) * | 2015-02-16 | 2016-08-25 | Biota Pharmaceuticals, Inc. | Compounds for treating respiratory syncytial virus infections |
WO2017060488A1 (en) * | 2015-10-09 | 2017-04-13 | Almirall, S.A. | New trpa1 antagonists |
-
2020
- 2020-10-14 TW TW109135461A patent/TW202128705A/zh unknown
- 2020-10-14 KR KR1020227016330A patent/KR20220084127A/ko unknown
- 2020-10-14 CN CN202080071930.XA patent/CN114945408B/zh active Active
- 2020-10-14 AU AU2020366678A patent/AU2020366678A1/en active Pending
- 2020-10-14 BR BR112022003729A patent/BR112022003729A2/pt not_active Application Discontinuation
- 2020-10-14 JP JP2022522350A patent/JP7354438B2/ja active Active
- 2020-10-14 WO PCT/EP2020/078855 patent/WO2021074197A1/en unknown
- 2020-10-14 CA CA3153115A patent/CA3153115A1/en active Pending
- 2020-10-14 EP EP20789985.7A patent/EP4045144A1/en active Pending
- 2020-10-14 MX MX2022004564A patent/MX2022004564A/es unknown
- 2020-10-14 AR ARP200102838A patent/AR120221A1/es unknown
- 2020-10-15 US US17/071,092 patent/US20210107919A1/en not_active Abandoned
-
2021
- 2021-09-01 US US17/463,942 patent/US11578080B2/en active Active
-
2022
- 2022-03-25 CL CL2022000757A patent/CL2022000757A1/es unknown
- 2022-04-10 IL IL292095A patent/IL292095A/en unknown
Also Published As
Publication number | Publication date |
---|---|
US20210395267A1 (en) | 2021-12-23 |
EP4045144A1 (en) | 2022-08-24 |
CN114945408B (zh) | 2024-04-16 |
CA3153115A1 (en) | 2021-04-22 |
WO2021074197A1 (en) | 2021-04-22 |
KR20220084127A (ko) | 2022-06-21 |
CN114945408A (zh) | 2022-08-26 |
JP7354438B2 (ja) | 2023-10-02 |
JP2022551956A (ja) | 2022-12-14 |
US11578080B2 (en) | 2023-02-14 |
TW202128705A (zh) | 2021-08-01 |
IL292095A (en) | 2022-06-01 |
MX2022004564A (es) | 2022-05-06 |
US20210107919A1 (en) | 2021-04-15 |
BR112022003729A2 (pt) | 2022-05-31 |
AR120221A1 (es) | 2022-02-02 |
AU2020366678A1 (en) | 2022-03-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DOP2019000005A (es) | 3-metil pirazinas 2,5-disustituidas y 3-metil pirazinas 2,5,6-trisustituidas como inhibidores alostéricos de shp2 | |
BR112019005595A2 (pt) | compostos e métodos para modulação de ido e tdo, e indicações para os mesmos | |
CO2021005987A2 (es) | Compuestos de anillo fusionado | |
CO2018003500A2 (es) | Anticuerpos anti-pd-1 y composiciones | |
CO2017011535A2 (es) | Composiciones de ácido obeticólico y métodos de uso | |
CO2017011851A2 (es) | Compuestos novedosos | |
CL2018001899A1 (es) | Salicilamidas de espiroheptanos y compuestos relacionados como inhibidores de cinasa rho (rock) | |
AR128259A2 (es) | Dihidropirimidinonas bicíclicas sustituidas y su uso como inhibidores de la actividad de elastasa neutrofílica | |
CL2021002882A1 (es) | Inhibidores de fgfr y métodos de uso de los mismos | |
CR20180029A (es) | Inhibidores peotídicos del receptor de interleucina 23 y su uso para tratar enfermedades inflamatorias | |
GT201600147A (es) | Compuestos derivados y composiciones de n-azaspirocicloalcano n-heteroaril sustituido para inhibir la actividad de shp2 | |
UY36215A (es) | Espirocicloheptanos como inhibidores de rock | |
PE20180243A1 (es) | Composiciones que comprenden cepas bacterianas | |
BR112018003212A2 (pt) | diacereína ou seus análogos para inibir a expressão de asc, expressão de nlrp3 e / ou formação de complexo inflamassoma nlrp3 | |
CL2021001395A1 (es) | Compuestos derivados de panteteínas cíclicas; composición farmacéutica que los comprende; y su uso para aumentar las concentraciones de acetil-coa, para el tratamiento de cáncer, enfermedad inflamatoria, enfermedad neurodegenerativa, esclerosis múltiple, entre otras enfermedades. | |
CR20190394A (es) | Compuestos de inhibidores de autotaxina | |
AR103895A1 (es) | Lactamas como inhibidores de rock | |
BR112017012504A2 (pt) | derivados de piperidina como inibidores de hdac1/2 | |
EA202091731A1 (ru) | Ингибиторы аутотаксина и их применения | |
UY36224A (es) | Compuestos tricíclicos de imidazo-pirimidinona | |
UY35357A (es) | Dihidropirimidinonas bicíclicas sustituidas y su uso como inhibidores de la actividad de elastasa n eutrofílica | |
PL410665A1 (pl) | Inhibitory arginazy oraz ich zastosowania terapeutyczne | |
CL2019000476A1 (es) | Compuestos de heteroarilcarboxamida como inhibidores de ripk2. | |
CO2022002622A2 (es) | Anticuerpos anti-cd73 y composiciones | |
CO2017000745A2 (es) | Dihidropirimidinonas bicíclicas sustituidas y su uso como inhibidores de la actividad de elastasa neutrófila |